ProShare Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
|
|||||
|
2025
Q1 | $1.62M | Sell |
|
|||||
|
2024
Q4 | $1.88M | Buy |
|
|||||
|
2024
Q3 | $976K | Buy |
|
|||||
|
2024
Q2 | $924K | Sell |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q4 | $859K | Buy |
|
|||||
|
2023
Q3 | $435K | Buy |
|
|||||
|
2023
Q2 | $683K | Buy |
|
|||||
|
2023
Q1 | $668K | Sell |
|
|||||
|
2022
Q4 | $886K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $391K | Sell |
|
|||||
|
2021
Q4 | $422K | Sell |
|
|||||
|
2021
Q3 | $399K | Sell |
|
|||||
|
2021
Q2 | $577K | Buy |
|
|||||
|
2021
Q1 | $532K | Buy |
|
|||||
|
2020
Q4 | $481K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $245K | Buy |
|
|||||
|
2018
Q2 | $214K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $3K | Sell |
|
|||||
|
2015
Q4 | $5K | Sell |
|
|||||
|
2015
Q3 | $196K | Sell |
|
|||||
|
2015
Q2 | $265K | Buy |
|
|||||
|
2015
Q1 | $195K | Buy |
|
|||||
|
2014
Q4 | $228K | Buy |
|
|||||
|
2014
Q3 | $239K | Sell |
|
|||||
|
2014
Q2 | $347K | Sell |
|
|||||
|
2014
Q1 | $499K | Buy |
|
|||||
|
2013
Q4 | $211K | Sell |
|
|||||
|
2013
Q3 | $315K | Buy |
|
|||||
|
2013
Q2 | $195K | Buy |
|